ArticleJournal of biomedical nanotechnology2009

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

Ping Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.